BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31649318)

  • 1. Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy.
    Beckham TH; Leeman JE; Xie P; Li X; Goldman DA; Zhang Z; Sherman E; McBride S; Riaz N; Lee N; Tsai CJ
    Br J Cancer; 2019 Nov; 121(11):897-903. PubMed ID: 31649318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
    Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
    Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
    Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
    JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
    Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors.
    Hobday SB; Brody RM; Kriegsman B; Basu D; Newman J; Cohen RB; Lukens JN; Singh A; D'Avella CA; Sun L
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):918-926. PubMed ID: 35980666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
    Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
    Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
    Zandberg DP; Algazi AP; Jimeno A; Good JS; Fayette J; Bouganim N; Ready NE; Clement PM; Even C; Jang RW; Wong S; Keilholz U; Gilbert J; Fenton M; Braña I; Henry S; Remenar E; Papai Z; Siu LL; Jarkowski A; Armstrong JM; Asubonteng K; Fan J; Melillo G; Mesía R
    Eur J Cancer; 2019 Jan; 107():142-152. PubMed ID: 30576970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.
    Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS
    Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
    Rambeau A; Bastit V; Thureau S; Thariat J; Moldovan C; Roge M; Babin E; Gery B; Di Fiore F; Florescu C; Clatot F
    Oral Oncol; 2019 Jun; 93():46-51. PubMed ID: 31109695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.
    Sridharan V; Rahman RM; Huang RY; Chau NG; Lorch JH; Uppaluri R; Haddad RI; Hanna GJ; Schoenfeld JD
    Oral Oncol; 2018 Oct; 85():29-34. PubMed ID: 30220316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing.
    LaVigne AW; Margalit DN; Rawal B; Puzanov M; Annino DJ; Goguen LA; Sher DJ; Schoenfeld JD; Chau NG; Lorch JH; Rabinowits G; Haddad RI; Tishler RB
    Head Neck; 2019 Apr; 41(4):959-966. PubMed ID: 30620435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck.
    Vincent AG; Wang W; Shokri T; Ducic Y
    Laryngoscope; 2021 May; 131(5):E1476-E1480. PubMed ID: 33044014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-Cause 30-Day Mortality After Surgical Treatment for Head and Neck Squamous Cell Carcinoma in the United States.
    Bukatko AR; Patel PB; Kakarla V; Simpson MC; Adjei Boakye E; Patel SH; Stamatakis KA; Varvares MA; Osazuwa-Peters N
    Am J Clin Oncol; 2019 Jul; 42(7):596-601. PubMed ID: 31166207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment.
    Kang HS; Roh JL; Kim MJ; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):295-304. PubMed ID: 26341665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
    JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.